Matthew P. Kowalsky
Chief Administrative Officer presso SIGILON THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/07/2023
Profilo
Matthew P.
Kowalsky is currently the Secretary & Chief Legal Officer at Sigilon Therapeutics, Inc. and the Chief Legal Officer at Enanta Pharmaceuticals, Inc. Previously, he worked as the Assistant General Counsel at ARIAD Pharmaceuticals, Inc., the Associate General Counsel at Cubist Pharmaceuticals LLC, the Senior Corporate Counsel at Genzyme Corp., the Secretary & Vice President-Legal at Proteon Therapeutics, Inc., and the Assistant General Counsel at Lantheus Medical Imaging, Inc. He obtained his undergraduate degree from the University of Notre Dame and his graduate degree from the University of Notre Dame The Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/08/2023 | 0 ( -.--% ) | - $ | 31/07/2023 |
Posizioni attive di Matthew P. Kowalsky
| Società | Posizione | Inizio |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Administrative Officer | - |
| ENANTA PHARMACEUTICALS, INC. | General Counsel | 30/04/2024 |
Precedenti posizioni note di Matthew P. Kowalsky
| Società | Posizione | Fine |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | General Counsel | 01/01/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/05/2016 |
| CUBIST PHARMACEUTICALS INC | General Counsel | 01/01/2015 |
| ARIAD PHARMACEUTICALS, INC. | General Counsel | 01/11/2013 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | General Counsel | 01/01/2013 |
Formazione di Matthew P. Kowalsky
| University of Notre Dame | Undergraduate Degree |
| University of Notre Dame The Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
- Borsa valori
- Insiders
- Matthew P. Kowalsky
